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Background
Psychological disorders and quality of life in diabetic
patients has received much attention in the literature [1-
4]. The aim of our study was to evaluate the prevalence of
depression, anxiety and various aspects of positive well-
being in uncontrolled adults with Type 2 diabetes.
Materials and methods
72 out-patients with type 2 diabetes, aged 32-83 years old,
38 men and 34 women, completed the Hospital Anxiety
and Depression Scale and the Well-Being Questionnaire,
whilst waiting for their first diabetes appointment. Demo-
graphic characteristics, details of diabetes status and
HbA1c were recorded. None of these patients was under
psychological treatment or had previously consulted a
psychiatrist.
Results
62,5% of the patients reported either anxiety or depressive
symptoms and 31,9% reported both. 20,8% of the
patients reported mild anxiety and 23,6% moderate to
severe anxiety, while 27,8% reported mild depression and
22,2% moderate to severe depression.
Women were more likely to report mild anxiety and mod-
erate to severe depression, while mean WBQ positive well-
being score was significantly higher in men (p=0,05).
Duration of diabetes was positively correlated with WBQ
depression score (r=0,306; p=0,009) and negatively corre-
lated with WBQ energy (r= −0,241; p=0,041), WBQ posi-
tive well-being (r= −0,253; p=0,032) and WBQ total score
(r= −0,250; p=0,034). HbA1c was positively correlated
with HADS anxiety score (r=0,239; p=0,043).
Conclusions
Prevalence rates of psychological symptoms in this
uncontrolled diabetic population were high. Diabetes'
duration was significantly associated with levels of depres-
sion and various aspects of positive well-being, while gly-
caemic control was related to levels of anxiety. Women
reported higher levels of psychological symptoms. A con-
siderable proportion of diabetics require psychological
support, which, if available, might help improve glycae-
mic control and overall well-being.
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